OTCPK:TDMM.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. More Details


Snowflake Analysis

Flawless balance sheet with high growth potential.

Share Price & News

How has Mach7 Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TDMM.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

TDMM.F

2.6%

US Healthcare Services

2.3%

US Market


1 Year Return

81.1%

TDMM.F

68.7%

US Healthcare Services

17.2%

US Market

Return vs Industry: TDMM.F exceeded the US Healthcare Services industry which returned 67.9% over the past year.

Return vs Market: TDMM.F exceeded the US Market which returned 15.8% over the past year.


Shareholder returns

TDMM.FIndustryMarket
7 Day0%2.6%2.3%
30 Day16.4%0.02%-4.6%
90 Day29.4%13.7%7.4%
1 Year81.1%81.1%69.2%68.7%19.8%17.2%
3 Yearn/a102.3%100.8%37.4%28.3%
5 Yearn/a169.9%167.0%83.8%63.0%

Price Volatility Vs. Market

How volatile is Mach7 Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Mach7 Technologies undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TDMM.F ($0.82) is trading below our estimate of fair value ($1.67)

Significantly Below Fair Value: TDMM.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TDMM.F is poor value based on its PE Ratio (1148.4x) compared to the US Healthcare Services industry average (63.8x).

PE vs Market: TDMM.F is poor value based on its PE Ratio (1148.4x) compared to the US market (18x).


Price to Earnings Growth Ratio

PEG Ratio: TDMM.F is poor value based on its PEG Ratio (11.7x)


Price to Book Ratio

PB vs Industry: TDMM.F is good value based on its PB Ratio (4.7x) compared to the US Healthcare Services industry average (5.2x).


Next Steps

Future Growth

How is Mach7 Technologies forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

97.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TDMM.F's forecast earnings growth (97.9% per year) is above the savings rate (2.2%).

Earnings vs Market: TDMM.F's earnings (97.9% per year) are forecast to grow faster than the US market (22.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: TDMM.F's revenue (21.2% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: TDMM.F's revenue (21.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TDMM.F's Return on Equity is forecast to be low in 3 years time (15%).


Next Steps

Past Performance

How has Mach7 Technologies performed over the past 5 years?

25.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TDMM.F has high quality earnings.

Growing Profit Margin: TDMM.F became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: TDMM.F has become profitable over the past 5 years, growing earnings by 25.4% per year.

Accelerating Growth: TDMM.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: TDMM.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).


Return on Equity

High ROE: TDMM.F's Return on Equity (0.3%) is considered low.


Next Steps

Financial Health

How is Mach7 Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: TDMM.F's short term assets (A$53.4M) exceed its short term liabilities (A$6.5M).

Long Term Liabilities: TDMM.F's short term assets (A$53.4M) exceed its long term liabilities (A$1.6M).


Debt to Equity History and Analysis

Debt Level: TDMM.F is debt free.

Reducing Debt: TDMM.F has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.

Debt Coverage: TDMM.F has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: TDMM.F has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Mach7 Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate TDMM.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TDMM.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TDMM.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TDMM.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TDMM.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Mike Lampron

1.5yrs

Tenure

AU$862,985

Compensation

Mr. Michael Lampron, also known as Mike, serves as Managing Director and Director of Mach7 Technologies Limited since June 24, 2019 and also serves as Chief Executive Officer. Mr. Lampron had been Chief Op ...


CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD614.44K) is below average for companies of similar size in the US market ($USD1.35M).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Michael Lampron
CEO, MD & Director1.5yrsAU$862.99k0.036%
A$ 69.4k
Ravi Krishnan
Founder & Chief Strategy Officer3.5yrsAU$510.91k2.47%
A$ 4.7m
Jennifer Pilcher
Global CFO & Corporate Secretaryno dataAU$630.74k0.12%
A$ 237.8k
Travis Nuzzi
Vice President of Sales and Marketing1.33yrsno datano data

1.5yrs

Average Tenure

Experienced Management: TDMM.F's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Michael Lampron
CEO, MD & Director1.5yrsAU$862.99k0.036%
A$ 69.4k
Per Larsen
Member of Industry Advisory Board2.5yrsno datano data
Eliot Siegel
Independent Non-Executive Director2.08yrsAU$40.68kno data
David Chambers
Independent Chairman of the Board1.25yrsAU$52.46k0.022%
A$ 42.7k
James Alland
Member of Industry Advisory Boardno datano datano data
Francisco Sapori
Member of Industry Advisory Boardno datano datano data
Sean Moynihan
Member of Industry Advisory Boardno datano datano data
Jeff Weil
Member of Industry Advisory Boardno datano datano data
Robert Bazzani
Independent Non-Executive Director0.67yrAU$61.58k0.011%
A$ 20.4k

1.3yrs

Average Tenure

Experienced Board: TDMM.F's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: TDMM.F insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56%.


Top Shareholders

Company Information

Mach7 Technologies Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Mach7 Technologies Limited
  • Ticker: TDMM.F
  • Exchange: OTCPK
  • Founded: 2007
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$268.361m
  • Listing Market Cap: AU$191.072m
  • Shares outstanding: 234.38m
  • Website: https://www.mach7t.com

Number of Employees


Location

  • Mach7 Technologies Limited
  • 120 Kimball Avenue
  • Suite 210
  • South Burlington
  • Vermont
  • 5403
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
M7TASX (Australian Securities Exchange)YesOrdinary SharesAUAUDApr 2016
M7TCHIA (Chi-X Australia)YesOrdinary SharesAUAUDApr 2016
TDMM.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2016

Biography

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. It offers Management Studio that enables healthcare delive ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/30 00:14
End of Day Share Price2020/09/02 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.